T. Rowe Price Investment Management’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.15B	Sell	17,523,840 -192,532	-1%	-$12.2M	0.8%	25
2025 Q4	$1.13B	Sell	17,716,372 -1,364,124	-7%	-$84.9M	0.71%	31
2025 Q3	$1.05B	Buy	19,080,496 +1,478,056	+8%	+$60.9M	0.64%	32
2025 Q2	$582M	Buy	17,602,440 +7,647,189	+77%	+$266M	0.37%	75
2025 Q1	$400M	Sell	9,955,251 -796,872	-7%	-$36.6M	0.26%	109
2024 Q4	$506M	Buy	10,752,123 +1,062,136	+11%	+$55.2M	0.31%	92
2024 Q3	$512M	Buy	9,689,987 +1,551,310	+19%	+$86.5M	0.31%	88
2024 Q2	$441M	Buy	8,138,677 +3,017,088	+59%	+$182M	0.28%	94
2024 Q1	$359M	Buy	5,121,589 +2,892,104	+130%	+$224M	0.22%	117
2023 Q4	$186M	Buy	2,229,485 +413,299	+23%	+$15M	0.12%	195
2023 Q3	$53.5M	Buy	1,816,186 +11,870	+0.7%	+$395K	0.04%	354
2023 Q2	$58.9M	Buy	1,804,316 +286,254	+19%	+$10.6M	0.04%	353
2023 Q1	$53.4M	Buy	1,518,062 +1,054,416	+227%	+$43M	0.04%	357
2022 Q4	$21.2M	Buy	+463,646	New	+$19.9M	0.02%	451